1. Home
  2. MAT vs LGND Comparison

MAT vs LGND Comparison

Compare MAT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mattel Inc.

MAT

Mattel Inc.

HOLD

Current Price

$15.18

Market Cap

4.5B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$214.76

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAT
LGND
Founded
1945
1987
Country
United States
United States
Employees
N/A
68
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MAT
LGND
Price
$15.18
$214.76
Analyst Decision
Buy
Strong Buy
Analyst Count
11
7
Target Price
$20.90
$256.29
AVG Volume (30 Days)
4.6M
163.4K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$5,347,623,000.00
N/A
Revenue This Year
$5.92
$1.25
Revenue Next Year
$5.08
$19.41
P/E Ratio
$75.65
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$14.10
$98.90
52 Week High
$22.48
$247.38

Technical Indicators

Market Signals
Indicator
MAT
LGND
Relative Strength Index (RSI) 52.81 45.19
Support Level $14.38 $180.85
Resistance Level $15.37 $232.12
Average True Range (ATR) 0.47 9.98
MACD 0.05 -2.18
Stochastic Oscillator 63.68 34.35

Price Performance

Historical Comparison
MAT
LGND

About MAT Mattel Inc.

Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the remainder stemming from international markets.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: